Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Trulieve Cannabis Corp TCNNF


Primary Symbol: C.TRUL Alternate Symbol(s):  C.TRUL.NT.U

Trulieve Cannabis Corp. is a vertically integrated cannabis company. The Company has established cannabis operations in three hubs: Southeast, Northeast, and Southwest. Its three regional hubs are anchored by market positions in cornerstone states of Florida, Pennsylvania, and Arizona. The Company operates in regulated markets that require knowledge in cultivation, manufacturing, and retail. The Company utilizes various extraction techniques, including critical ethanol extraction, carbon dioxide extraction, hydrocarbon extraction, and mechanical separation. In addition, the Company owns and utilizes carbon dioxide extraction, distillation, purification and manufacturing technology that is used to produce a range of cannabis topicals and vapes featuring cannabinoids. The Company's brands include premium tier brands Avenue, Cultivar Collection, and Muse; mid-tier brands Modern Flower, Alchemy, Momenta, and Sweet Talk, and value tier brands Co2lors, Loveli, Roll One, and Trekkers.


CSE:TRUL - Post by User

Post by retiredcfon Dec 15, 2021 6:36am
306 Views
Post# 34231755

Canaccord 2022 Top Picks

Canaccord 2022 Top Picks

Positioned for healthy growth ahead with transformational acquisition in the rearview

We are re-introducing Trulieve as our Top Pick for 2022 and reiterating our $97.00 target price. On a YTD basis, Trulieve returned -19%, vs. the broader US Cannabis Index which declined ~14%. 2021 marked a transformative year for the company with the acquisition of Harvest Health & Wellness, which helped increase the company’s overall footprint to 11 states, in addition to retaining its status as the industry's profitability leader and maintaining a healthy balance sheet. Accordingly, we believe Trulieve is well positioned for healthy revenue and EBITDA growth in 2022.


<< Previous
Bullboard Posts
Next >>